Search results for: 'Global, 2024–2030'
- Did you mean
- global 2014 2014
- global 2014 2030
- Related search terms
- Global, Budgeting, Testing and Regulations for Autonomous Driving Solutions
- Global, Budgeting
- global, in vitro
- Global, Japan and the PRC Wheelchair Industry
-
23 Aug 2010  |  North America  |  Market Research
Vital Signs - Biomarkers for Improved and Accelerated Sepsis Treatment: Enabling Clinicians to Definitively Diagnose the Disease, Identify the Causative Agent, and Determine the Appropriate Type and Dosage of Antibiotic
This issue of Vital Signs, released on August 23, 2010, provides a strategic analysis of trends in biomarkers for improved and accelerated sepsis treatment. Additionally, a company spotlight is provided for BRAHMS, a global biotechnology company committed to improving healthcare through the discovery and development of novel and innovative bio...
$1,500.00